Natural products continue to be an important source of leads for new medicines, despite reduced interest from large pharmaceutical companies. Screening collections of natural products can be assembled ...
Protein–protein interactions represent a large and important class of targets for human therapeutics. However, developing small-molecule antagonists of protein–protein interactions is challenging, ...